Gene · 9656
MDC1: mediator of DNA damage checkpoint 1
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. MDC1: mediator of DNA damage checkpoint 1. Genes, record 9656. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/9656
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| Q14676 | Mediator of DNA damage checkpoint protein 1 | 2,089 | 12 | Ensembl, GeneID, HGNC |
Source UniProt
Patents76
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| JP 2026004568 A | 2026-01-14 | 52895 | Q14676 | Espacenet |
| JP 2026004568 A | 2026-01-14 | 52904 | Q14676 | Espacenet |
| JP 2026004568 A | 2026-01-14 | 52905 | Q14676 | Espacenet |
| JP 2026004568 A | 2026-01-14 | 52916 | Q14676 | Espacenet |
| JP 2026004568 A | 2026-01-14 | 52923 | Q14676 | Espacenet |
| JP 2026004568 A | 2026-01-14 | 52930 | Q14676 | Espacenet |
| EP 4650780 A2 | 2025-11-19 | 9775 | Q14676 | Espacenet |
| EP 4641201 A2 | 2025-10-29 | 10024 | Q14676 | Espacenet |
| JP 2025517969 A | 2025-06-12 | 10024 | Q14676 | Espacenet |
| JP 2025517970 A | 2025-06-12 | 9775 | Q14676 | Espacenet |
1 to 10 of 76
See all 76 patentsDrugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants1,846
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | MDC1 papers | Newest fiscal year |
|---|---|---|---|
| P01CA092584 | Structural Cell Biology of DNA Repair Machines | 28 | 2025 |
| P30CA016672 | Cancer Center Support Grant | 24 | 2025 |
| P30CA008748 | Cancer Center Support Grant | 20 | 2025 |
| P30CA015083 | Mayo Clinic Comprehensive Cancer Center Support Grant | 8 | 2025 |
| R01CA198279 | Shaping DNA Damage Response Networks Via Histone H2A Variants | 8 | 2025 |
| ZIABC006150 | DNA Repair, Cell Cycle Checkpoints and Apoptosis as Targets for Anticancer Drugs | 8 | 2025 |
| P30CA021765 | Cancer Center Support Grant (CCSG) | 6 | 2025 |
| P30CA046934 | University of Colorado Cancer Center Support Grant | 6 | 2025 |
| P50CA116201 | Mayo Clinic Breast Cancer SPORE | 6 | 2025 |
| R01CA132878 | Post-translational Modifications in DNA Damage Response: a Structural Perspective | 6 | 2025 |
1 to 10 of 1,846Source NIH's project files
See all 1,846 nih grantsPapers2,704
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| MCPH1 and DNA Damage Response Pathway Genes as Candidate Susceptibility Loci in Hereditary Breast Cancer. | Diagnostics (Basel) | 2026 | 42793752 | PubTator, text mining | PubMed |
| A germline KDM3C polymorphism impairs DNA repair and sensitizes to chemoradiotherapy. | medRxiv | 2026 | 42732193 | PubTator, text mining | PubMed |
| Dynamic chromatin tethering of MDC1 regulates genome stability. | Nucleic Acids Res | 2026 | 42703974 | PubTator, text mining | PubMed |
| Impact of Infection-Related Immune Responses on ANCA-Associated Vasculitis in Finns: A Mendelian Randomization Study. | Genet Res (Camb) | 2026 | 42634225 | PubTator, text mining | PubMed |
| Targeting THOC2-Mediated mRNA Export Induces PARP Inhibitor Vulnerability in DNA Repair-Competent Hepatocellular Carcinoma. | Int J Biol Sci | 2026 | 42328459 | PubTator, text mining | PubMed |
| Lactate-Associated Gene Signatures as Predictors: A Comprehensive Analysis of Immune Profiles in Sepsis. | J Intensive Care Med | 2026 | 42286943 | PubTator, text mining | PubMed |
| MDC1 promotes nuclear localization of Beclin-1 and supports its role in ATM pathway in response to oxidative stress. | Eur J Cell Biol | 2026 | 42013721 | PubTator, text mining | PubMed |
| RNF126 and BRAP safeguard genome integrity after DNA damage in late mitosis. | Cell Rep | 2026 | 41996237 | PubTator, text mining | PubMed |
| Whole-exome sequencing unveils novel potential gene mutations involved in primary renal small cell carcinoma. | Oncol Lett | 2026 | 41969585 | PubTator, text mining | PubMed |
| Computational phosphoproteomic insights into predominant BRAF phosphosites and associated regulatory networks in cancer. | Biochim Biophys Acta Proteins Proteom | 2026 | 41936939 | PubTator, text mining | PubMed |
1 to 10 of 2,704
See all 2,704 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/9656
GET https://conductscience.org/api/genes/v1/9656/patents?page=2